Abstract: Methods for extracting metabolites from mushroom comprising dispersing a sample of the mushroom; contacting the sample with a first solvent system at a temperature of 80° C. or greater to extract at least a first portion of metabolites from the sample; and contacting the sample with a second solvent system at a temperature of 80° C. or greater to extract at least a second portion of metabolites from the sample, wherein the combined first portion of metabolites and the second portion of metabolites include primary and secondary metabolites from the mushroom. A high-throughput process for establishing a metabolic profile of a mushroom, such as Amanita mushroom, can comprise extracting metabolites from mushroom and analyzing the extracted metabolites by automatic peak recognition or peak integration. Assay for identifying and/or assessing candidate metabolites extracted from Amanita mushroom are also disclosed.

Abstract: Methods for extracting metabolites from mushroom comprising dispersing a sample of the mushroom; contacting the sample with a first solvent system at a temperature of 80° C. or greater to extract at least a first portion of metabolites from the sample; and contacting the sample with a second solvent system at a temperature of 80° C. or greater to extract at least a second portion of metabolites from the sample, wherein the combined first portion of metabolites and the second portion of metabolites include primary and secondary metabolites from the mushroom. A high-throughput process for establishing a metabolic profile of a mushroom, such as Amanita mushroom, can comprise extracting metabolites from mushroom and analyzing the extracted metabolites by automatic peak recognition or peak integration. Assay for identifying and/or assessing candidate metabolites extracted from Amanita mushroom are also disclosed.

Abstract: Disclosed herein are nanostructures comprising a cell membrane-derived material comprising a target membrane protein; and one or more magnetic nanoparticles; wherein the cell membrane-derived material encapsulates the one or more magnetic nanoparticles. Also disclosed are methods of screening a sample for a binding agent, the method comprising contacting a sample comprising a binding agent with a nanostructure to form a mixture, the nanostructure comprising a cell membrane-derived material comprising a target membrane protein; and one or more magnetic nanoparticles; wherein the cell membrane-derived material encapsulates the one or more magnetic nanoparticles; and separating the nanostructure and any binding agent bound thereto from the mixture with a magnet.